AU659422B2 - Composition containing antihistamine H2 receptor antagonists and bioadhesive material - Google Patents

Composition containing antihistamine H2 receptor antagonists and bioadhesive material

Info

Publication number
AU659422B2
AU659422B2 AU89098/91A AU8909891A AU659422B2 AU 659422 B2 AU659422 B2 AU 659422B2 AU 89098/91 A AU89098/91 A AU 89098/91A AU 8909891 A AU8909891 A AU 8909891A AU 659422 B2 AU659422 B2 AU 659422B2
Authority
AU
Australia
Prior art keywords
histamine
receptor antagonist
treatment
cimetidine
gastric
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU89098/91A
Other languages
English (en)
Other versions
AU8909891A (en
Inventor
Mark Coke
Adrian Francis Davis
John Edward O'mullane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Publication of AU8909891A publication Critical patent/AU8909891A/en
Application granted granted Critical
Publication of AU659422B2 publication Critical patent/AU659422B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
AU89098/91A 1990-11-27 1991-11-21 Composition containing antihistamine H2 receptor antagonists and bioadhesive material Ceased AU659422B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9025710 1990-11-27
GB909025710A GB9025710D0 (en) 1990-11-27 1990-11-27 Novel treatment
PCT/GB1991/002063 WO1992009286A1 (en) 1990-11-27 1991-11-21 Composition containing antihistamine h2 receptor antagonists and bioadhesive material

Publications (2)

Publication Number Publication Date
AU8909891A AU8909891A (en) 1992-06-25
AU659422B2 true AU659422B2 (en) 1995-05-18

Family

ID=10686017

Family Applications (1)

Application Number Title Priority Date Filing Date
AU89098/91A Ceased AU659422B2 (en) 1990-11-27 1991-11-21 Composition containing antihistamine H2 receptor antagonists and bioadhesive material

Country Status (9)

Country Link
EP (1) EP0559812A1 (ja)
JP (1) JPH06502855A (ja)
AU (1) AU659422B2 (ja)
CA (1) CA2096962A1 (ja)
GB (1) GB9025710D0 (ja)
IE (1) IE914091A1 (ja)
PL (1) PL168421B1 (ja)
WO (1) WO1992009286A1 (ja)
ZA (1) ZA919290B (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4139883A1 (de) * 1991-11-29 1993-06-03 Michael Prof Dr Dittgen Verfahren zur herstellung bioadhaesiver arzneimittel
AU7322394A (en) * 1993-07-06 1995-02-06 Mcneil-Ppc, Inc. H2 antagonist-sucralfate-antiflatulent combinations
WO1995010274A1 (en) * 1993-10-14 1995-04-20 F.H. Faulding & Co. Limited Aqueous pharmaceutical composition
GB9407235D0 (en) * 1994-04-12 1994-06-08 Glaxo Group Ltd Pharmaceutical compositions
US5593696A (en) * 1994-11-21 1997-01-14 Mcneil-Ppc, Inc. Stabilized composition of famotidine and sucralfate for treatment of gastrointestinal disorders
KR19980703526A (ko) * 1995-04-03 1998-11-05 나가야마오사무 수크랄페이트 함유 제제 조성물
EP0974361A4 (en) * 1996-02-08 2003-05-02 Chugai Pharmaceutical Co Ltd METHOD OF USING AN ANTI-ACID AGENT AND PHARMACEUTICAL PREPARATION CONTAINING THE SAME
WO1999049872A1 (fr) * 1998-04-01 1999-10-07 Chugai Seiyaku Kabushiki Kaisha Medicaments preventifs des gastrites alcooliques
US6319513B1 (en) 1998-08-24 2001-11-20 The Procter & Gamble Company Oral liquid mucoadhesive compounds
WO2023218480A1 (en) * 2022-05-09 2023-11-16 Syri Research Private Limited Liquid oral formulation of famotidine or pharmaceutically acceptable salt thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3710462A1 (de) * 1987-03-30 1988-10-13 Heumann Pharma Gmbh & Co Pharmazeutische zubereitung zur behandlung von erkrankungen des magen-darm-traktes
US4975281A (en) * 1989-01-30 1990-12-04 E. R. Squibb & Sons, Inc. Anti-ulcer composition
EP0403048A3 (en) * 1989-06-14 1991-01-30 Warner-Lambert Company Medicated compositions containing sucralfate and processes for their production

Also Published As

Publication number Publication date
ZA919290B (en) 1992-09-30
WO1992009286A1 (en) 1992-06-11
IE914091A1 (en) 1992-06-03
GB9025710D0 (en) 1991-01-09
JPH06502855A (ja) 1994-03-31
EP0559812A1 (en) 1993-09-15
AU8909891A (en) 1992-06-25
CA2096962A1 (en) 1992-05-28
PL168421B1 (en) 1996-02-29

Similar Documents

Publication Publication Date Title
US5629026A (en) Compositions containing histamine-H2-receptor antagonists at low dosage
CA2074215C (en) Improved oral dosing formulations of dideoxy purine nucleosides
HU211236A9 (en) Antacide compositions with prolonged gastric residence time
JPH05112445A (ja) 作用開始を速くし潜在特性を増加させる移送システム
MXPA04000223A (es) Formas de dosis de bencimidazol substituidas novedosas y metodo para usar las mismas.
AU659422B2 (en) Composition containing antihistamine H2 receptor antagonists and bioadhesive material
EP1086701A2 (en) Simethicone containing laxative composition
EP0533770A1 (en) Novel treatment
AU4082793A (en) Compositions based on histamine h2-receptor antagonists and cationic exchangers complexes
EP0492247A1 (en) Effervescent H2 blocker formulation
EP0777470A1 (en) Use of paracellular absorption enhancers such as glucose for enhancing the absorption of histamine h2-antagonists
EP0715520B1 (en) Use of a suspension based on sucralphate gel as antacid
AU677108B2 (en) Ranitidine and calcium carbonate pharmaceutical combination product
JPH10236959A (ja) 制酸剤含有組成物
WO1996002262A2 (en) Pharmaceutical compositions for the treatment of gastrointestinal distress comprising h2 receptor antagonists and antacids